Biotechnology/Chemical/Pharmaceutical Customer Partnership

Thursday November 10th, 2005
United States Patent and Trademark Office
Remsen Building, Lobby Conference Room
400 Dulany Street
Alexandria, Virginia

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on June 15, 2005 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Thursday November 10th from 9:00 am to 4:30 pm at the Lobby Conference Room in Remsen Building Building, 400 Dulany Street, Alexandria, Virginia.

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email to decline or confirm your attendance by November 4th, 2005.

Biotechnology/Chemical/Pharmaceutical Customer Partnership

Time Morning Session Presenter
Greetings and Overview
Jasemine C. Chambers, Bruce Kisliuk, George Elliott,
Directors, TC 1600
Pre-Appeal Conferences
and after final practice
Anton Fetting, Office of Patent
Legal Administration
Recent Biotech Case Law
Steve Walsh, Office of the Solicitor
Patents update/Forecasting
the new year???
John J. Doll, Commissioner for Patents
Time Afternoon Session Presenter
NAS Study of IPRs in Genomic
and Protein-Related inventions
Roderick McKelvie, Covington and Burling,
Former District Court Judge
Breaking Unity
Michael Woodward, TQAS; TC1600
Deposits Rules and How
to obtain Biological Deposits
Gary Benzion, Supervisory Patent Examiner, and Michael Woodward, TQAS; TC1600
Closing Remarks/Discussion
Jasemine C. Chambers, Bruce Kisliuk, George Elliott, Directors, TC 1600